Suzanne M. Hanlon, Secretary, General Counsel & VP HR at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 3,000 shares at $10.53 ($32K) on 2016-08-16, disclosed to the SEC on 2016-08-17.
Open-market sale of $32k ZYNE by Secretary, General Counsel & VP HR. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.